NCT06299514View on ClinicalTrials.gov

RAFT - Pace &Ablate

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 25, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Atrial FibrillationHeart FailurePacemakerArrhythmia Atrial
Interventions
DEVICE

Pace and Ablate

Conduction System Pacing (CSP) followed by AtrioVentricular Node Ablation (AVNA)

DRUG

Medication

Optimization of heart failure therapies includes maximum tolerated doses of beta-blockers, aldosterone antagonists, ACE inhibitors, ARB, diuretics, ARNis

Trial Locations (2)

N6A5A5

RECRUITING

London Health Sciences Centre - University Hospital, London

N6G5A5

NOT_YET_RECRUITING

London Health Sciences Research, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER